Renub Research

www.renub.com

Global Osteoporosis Market & Drugs Analysis 2010 2015

Publisher: Renub Research Published: August, 2011

Osteoporosis Market Overview

Osteoporosis is often called the "silent disease" because bone loss occurs without symptoms. It is characterized by low bone mass and micro-architectural deterioration of bone tissue, leading to bone fragility and a consequent increase in risk of fracture. Global osteoporosis market is expected to reach 16 Billion by 2015. This significant growth is primarily attributed to strong treatment options currently available in the market as well as strong pipeline products. The increase in the prevalence of osteoporosis among the female population is the principal driver of the osteoporosis market and will continue to be in the future. Fosamax was the undisputed leading product in the history of global osteoporosis drug market till 2007. It has a market share of nearly 37% in 2007 but, declined to 5% by 2015 due to patent expiry and competition from cheaper generics. Boniva and Evista were leading the osteoporosis market till 2010 but the dynamics of osteoporosis market is expected to change by 2011 as Prolia is going to be introduced in the market. It is predicted that Prolia will lead the market with nearly 45% share by 2015. The osteoporosis market offers multiple opportunities for current and future market players. In addition to increasing awareness, diagnosis and treatment, there is the need to develop new drugs that promote bone building. While the market awaits new growth, driven by the launch of several promising pipeline drugs, including Amgens Prolia (denosumab), companies are looking for innovative ways to maximize revenues from their products nearing the end of their lifecycles.

Report Details
Global Osteoporosis Market & Drugs Analysis 2010 2015 report published by Renub Research provides an in-depth analysis of the past, present and future prospects. The report has been researched at source globally and features latest available data covering: Global Osteoporosis Market (2009 to 2015) Four Osteoporosis Drug Class (Bisphosphonate, SERM, PTH and Calcitonin) market and market share data of (2006 to 2014)

Top Nine Osteoporosis Drug Brand (Fosamax, Actonel, Reclast, Boniva, Evista, Forteo, Viviant/Conbriza, Miacalcin, Prolia) sales and market share data of 2007 to 2015 Six Countries (USA, European Union, Japan, China, India, Korea) Osteoporosis market share data of (2009 to 2015) Six Countries (USA, European Union, Japan, China, India, Korea) Osteoporosis market data of (2005 to 2015) Pipeline Developmental Agents (Odanacatib, Aprela) Future Trends Key Companies (Eli Lilly, Roche, Amgen, Merck & Novartis) Analysis Revenue in Osteoporosis Market (2007 to 2010), Strength & Weakness in Osteoporosis Market

Research Highlights
Global Osteoporosis drug market is expected to reach the figure of US$ 16 Billion by 2015 United States Osteoporosis drug market was nearly US$ 5 Billion in 2010 United States & China together is expected to control 61% market share in osteoporosis drug market by 2015 Although SERM is increasing its market share year on year but Bisphosphonates will continue to dominate the osteoporosis drug class segment with 56% in 2014 Prolia will lead the Osteoporosis drug market with 45% share by 2015

Data Sources
Information and data in this report has been collected from various printable and nonprintable sources like Trade Journals, White papers, News websites, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases.

Renub Research

Page 3 of 16

About Us
Renub Research
in international is a leading Market Research and Information Analysis Company with Researches, Surveys, Business and Consulting.

centers at Noida India and Roswell USA. We have more than 7 years of experience especially Business-to-Business Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others. Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in todays ultra-competitive markets.

For more information on us or to view any of our sample work you can mail us at info@renub.com

Renub Research

Page 4 of 16

Published By

Renub Research
A116B, Sector27 Noida 201301 Phone: +91-120-421-9822, 254-5750 (India) +1-678-302-0700 (USA) Fax : +91-120-424-9780 Email: info@renub.com www.renub.com

Global Osteoporosis Market & Drugs Analysis 2010 2015 Renub Research, 2011 Edition 1.0 All rights reserved. This publication is protected by copyright. No part of it may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic mechanical, photocopying, recording or otherwise without the prior written permission of the publisher

Renub Research

Page 5 of 16

Table of Contents
1. 2. 3. Executive Summary Global Osteoporosis Market Global Osteoporosis Market Share (2007 2015) 3.1 3.2 3.3 By Drug Class - Osteoporosis Market Share & Forecast By Drug Market Share - Osteoporosis Market Share & Forecast By Country (USA, European Union, Japan, China, India, Korea) - Osteoporosis Drug Market

Share & Forecast 4. By Country Osteoporosis Market & Forecast (2008 2015) 4.1 4.2 4.3 4.4 4.5 4.6 5. United States Osteoporosis Market & Forecast European Union Osteoporosis Market & Forecast Japan Osteoporosis Market & Forecast China Osteoporosis Market & Forecast Korea Osteoporosis Market & Forecast India Osteoporosis Market & Forecast

Osteoporosis Drugs Classes Market & Forecast (2004 2014) 5.1 5.2 5.3 5.4 Global Bisphosphonate Market & Forecast Global Selective Estrogen Receptor Modulators (SERM) Market & Forecast Global Parathyroid Hormone (PTH) Market & Forecast Global Calcitonin Market & Forecast

6.

Osteoporosis Drugs Market Analysis & Forecast (2004 2015) 6.1 Bisphosphonate Drugs Market & Forecast Fosamax (Alendronate) Bonviva/Boniva (Ibandronic Acid) Reclast/Aclasta Actonel (Risedronate)

6.1.1 6.1.2 6.1.3 6.1.4 6.2

SERMs Drugs Market & Forecast Evista (Raloxifene) Viviant/ Conbriza (Bazedoxifene)

6.2.1 6.2.2

Renub Research

Page 6 of 16

6.3

Parathyroid Hormone Drugs Market & Forecast Forteo

6.3.1 6.4

Calcitonin Drugs Market & Forecast Miacalcin

6.4.1 6.5 7.

Prolia (Denosumab)

Pipeline Drugs in Osteoporosis Market Analysis 7.1 7.2 Odanacatib (MK 0822) Aprela (Bazedoxifene)

8. 9.

Licensing Deals in Osteoporosis Drug Market (2008 2009) Key Companies Analysis 9.1 Eli Lilly Eli Lilly Revenue in Osteoporosis Segment Strength Weaknesses

9.1.1 9.1.2 9.1.3 9.2

Roche Roche Revenue in Osteoporosis Segment Strength Weaknesses

9.2.1 9.2.2 9.2.3 9.3

Amgen Strength Weaknesses

9.3.1 9.3.2 9.4

Merck Merck Revenue in Osteoporosis Segment Strength Weaknesses

9.4.1 9.4.2 9.4.3 9.5

Novartis Novartis Revenue in Osteoporosis Segment Strength Weaknesses

9.5.1 9.5.2 9.5.3

Renub Research

Page 7 of 16

List of Figures:
Figure 2-1: Global Osteoporosis Market (Million US$), 2009 2010 Figure 2-2: Global Forecast for Osteoporosis Market (Million US$), 2011 2015 Figure 3-1: Global Osteoporosis Drug Class Market Share (Percent), 2006 2010 Figure 3-2: Global Forecast for Osteoporosis Drug Class Market Share (Percent), 2011 2014 Figure 3-3: Global Osteoporosis Drug Market Share (Percent), 2007 2010 Figure 3-4: Global Forecast for Osteoporosis Drug Market Share (Percent), 2011 2015 Figure 3-5: Global Osteoporosis Drug Market Share of (USA, European Union, Japan, China, India, Korea) (Percent), 2009 2010 Figure 3-6: Global Forecast for Osteoporosis Drug Market Share of (USA, European Union, Japan, China, India, Korea) (Percent), 2011 2015 Figure 4-1: United States Osteoporosis Market (Million US$), 2008 2010 Figure 4-2: United States Forecast for Osteoporosis Market (Million US$), 2011 2021 Figure 4-3: European Union Osteoporosis Market (Million US$), 2009 2010 Figure 4-4: European Union Forecast for Osteoporosis Market (Million US$), 2011 2015 Figure 4-5: Japan Osteoporosis Market (Billion Yen), 2001 2010 Figure 4-6: Japan Forecast for Osteoporosis Market (Billion Yen), 2011 2015 Figure 4-7: China Osteoporosis Market (Million US$), 2004 2010 Figure 4-8: China Forecast for Osteoporosis Market (Million US$), 2011 2015 Figure 4-9: Korea Osteoporosis Market (Million US$), 2001 2010 Figure 4-10: Korea Forecast for Osteoporosis Market (Million US$), 2011 2015 Figure 4-11: India Osteoporosis Market (Million INR), 2007 2010 Figure 4-12: India Forecast for Osteoporosis Market (Million INR), 2011 2015 Figure 5-1: Global Bisphosphonate Market (Million US$), 2004 2010 Figure 5-2: Global Forecast for Bisphosphonate Market (Million US$), 2011 2014 Figure 5-3: Global SERM Market (Million US$), 2004 2010 Figure 5-4: Global Forecast for SERM Market (Million US$), 2011 2014 Figure 5-5: Global PTH Market (Million US$), 2004 2010 Figure 5-6: Global Forecast for PTH Market (Million US$), 2011 2014 Figure 5-7: Global Calcitonin Market (Billion US$), 2004 2010 Figure 5-8: Global Forecast for Calcitonin Market (Billion US$), 2004 2010 Figure 6-1: Global Fosamax Drug Sales (Million US$), 2003 2010 Figure 6-2: Global Forecast for Fosamax Drug Sales (Million US$), 2011 2015 Figure 6-3: Global Boniva Drug Sales (Million US$), 2005 2010 Figure 6-4: Global Forecast for Boniva Drug Sales (Million US$), 2011 2015 Figure 6-5: Global Reclast/Aclasta Drug Sales (Million US$), 2007 2010

Renub Research

Page 8 of 16

Figure 6-6: Global Forecast for Reclast/Aclasta Drug Sales (Million US$), 2011 2015 Figure 6-7: Global Actonel Drug Sales (Million US$), 2004 2010 Figure 6-8: Global Forecast for Actonel Drug Sales (Million US$), 2011 2013 Figure 6-10: Global Evista Drug Sales (Million US$), 2001 2010 Figure 6-11: Global Forecast for Evista Drug Sales (Million US$), 2011 2015 Figure 6-12: Global Viviant/Conbriza Drug Sales (Million US$), 2010 2015 Figure 6-13: Global Forteo Drug Sales (Million US$), 2003 2010 Figure 6-14: Global Forecast for Forteo Drug Sales (Million US$), 2011 2015 Figure 6-15: Global Miacalcin Drug Sales (Million US$), 2004 2010 Figure 6-16: Global Forecast for Miacalcin Drug Sales (Million US$), 2011 2015 Figure 6-17: Global Forecast for Prolia Drug (Million US$), 2010 2016 Figure 7-1: Global Forecast for Odanacatib Drug (Million US$), 2012 2015 Figure 7-2: Global Forecast for Aprela Drug Sales (Million US$), 2011 2015 Figure 9-1: Eli Lilly Osteoporosis Drug Revenue (Million US$), 2007 2010 Figure 9-2: Roche Osteoporosis Drug Revenue (Million US$), 2007 2010 Figure 9-3: Merck Osteoporosis Drug Revenue (Million US$), 2007 2010 Figure 9-4: Novartis Osteoporosis Drug Revenue (Million US$), 2007 2010

Renub Research

Page 9 of 16

List of Tables:
Table 6-1: Actonel (Eisai, P&G and Sanofi-Aventis) Sales (Million US$), 2004 2013 Table 6-2: Benet (Risedronate) Sales (Million US$), 2004 2013 Table 9-1: Osteoporosis Drugs Cost Comparison (US$) in 1 Year

Renub Research

Page 10 of 16

Order Form
Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780 Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to info@renub.com

Format
Report Title: Global Osteoporosis Market & Drugs Analysis 2010 2015

Single User (Email from Publisher) US$ 950

Hard Copy (Mail Delivery) US$ 1,050

CD Rom (Mail Delivery) US$ 1,050

Global Site License (Multiple User License) US$ 1,500

For ordering this report: Three easy ways to place your order:
1) Order online by Credit Card (Visa, MasterCard, etc.): http://renub.com/reports/showdetails.aspx?id=48 2) Order by Wire Transfer: http://renub.com/reports/wiretransfer.aspx?id=48&pid=1170

To pay by Wire Transfer, please, fill in your contact details in the form below:

Renub Research

Page 11 of 16

Bank Details
Account Name: Renub Research A/C No.: 109102000023296 Name of Bank: IDBI Bank Ltd. Swift Code: IBKLINBB010 Bank Address: 4th Floor Indian Red Cross Building 1 Red Cross Road Opposite Parliament Street New Delhi 110001 India

Contact Information
First Name: Email: Job Title: Company: Address: City: Postal/Zip Code: Country: Phone: Mobile: Fax: Report Format: Your message: Last Name:

Renub Research

Page 12 of 16

3) Order by Check Please post the check accompanied by this form, to: Company Address: Renub Research A -116B Sector -27 Noida - 201301 Uttar Pradesh India Phone: +91-120-421-9822, 424-9780

For free Sample copy report or to view any of our sample work please contact us at info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)

Follow Us
Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090 LinkedIn: http://www.linkedin.com/company/renub-research Twitter: http://twitter.com/RenubResearch

Renub Research

Page 13 of 16

Related Reports
Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 2015) Global Molecular Diagnostics Market & Future Forecast 2010 - 2014 Alzheimers Disease Patients & Market Worldwide, Future Scenario (2010 2015) & Drugs Analysis Global Cardiovascular Surgery Devices Market Trends and Future Forecast (2009 - 2014) Personalized Medicine Market (2010 - 2015) - By Segments, Technologies, Opportunities, Challenges & Future Forecast World Vaccines Market: Vaccine Segments Analysis, Vaccine Cases and Future Forecast Global In Vitro Diagnostics (IVD) Market Trends and Future Forecast (2009 2014) Glucose Monitoring Devices Market Worldwide (2010 2014) Global Diabetes Market Trends & Future Forecast Diabetes Drug (Anti-Diabetic Drug), Insulin, DPP-IV, GLP-1 Asia Medical Tourism Analysis (2008 2013) Global Molecular Diagnostics Market: Opportunities & Future Forecast Insulin Delivery Devices Market Analysis and Future Forecast World Vaccines Market 2008-2013: Future Forecast, Critical Trends and Developments The World Diabetes Market, 2007-2025: An analysis of Diabetes Drug and Insulin Market

Renub Research

Page 14 of 16

Our Partial List of Clients

Redbus Becton Dickinson Pfizer Intercell Sanofi Pasteur Stanford Burgess Pequot Capital DMI Transgene S.A. Ixia communications Toyota Tsusho Amercia Inc. National Health Research Institutes Abbott Diabetes Care Corning Incorporated - Life Sciences L.E.K. Consulting GmbH Syntiron MediVas LLC Credit Suisse Dune Medical QIAGEN Inje University Mapp Biopharmaceutical Institute for Information Industry NorDiag ASA Renub Research Rep e Inv Medicas SA de Innogenetics Page 15 of 16

Bain WAKE Technology Services, Inc. PSS World Medical Relypsa C&K components Konkuk University Resonetics Samsung SEKISUI MEDICAL CO. LTD. Plentyoffish Media INC Arthur D Little Gmbh Morgan Stanley Takeda Pharmaceutical Corporation Hokkai School of Commerce Ministry of Manpower Singapore GenOmind, LLC. Goldman Sachs & Co NTT Advanced Technology Tokyo Womens Medical University The Chemo-Sero-Therapeutic Research Trade Council of Iceland Jpmorgan, Ets Trading GE Healthcare IT ixia communications

Disclaimer
This research report is published by Renub Research. All rights reserved. Reproduction or redistribution of this research report in any form for any business purpose is expressly prohibited without written permission of www.renub.com and any payments of a specified fee. Requests to republish any material may be sent to us at info@renub.com. Most of the information available in this report is within the public domain. The submitting authors or other copyright holders retain rights for reproduction or redistribution. All persons reproducing or redistributing this information are expected to adhere to the terms and constraints invoked by the copyright holder. Such protected material, however, may be used under the terms of "fair use as defined in the copyright laws, which generally permit use for non-commercial educational purposes such as teaching, research, criticism, and news reporting. With respect to documents available, neither the company nor any of its employees makes any warranty, express or implied, including the warranties of merchantability and fitness for a particular purpose, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately owned rights.

Renub Research

Page 16 of 16